The Role of Step Therapy in the Treatment of Migraine.
Leon S MoskatelNiushen ZhangPublished in: Current pain and headache reports (2023)
With the CGRP mAbs, gepants, and lasmiditan now on the market for up to 5 years, new research, including network meta-analyses and long-term use studies, can evaluate the comparative efficacy, tolerability, and adherence of these medications relative to older acute and preventive medications for the treatment of migraine. Deciding how medications are chosen for patients requires accounting for many factors including sustainability, efficacy, tolerability, and preference. Newer research can help give clarity on the appropriateness of gating certain treatment options behind others.
Keyphrases
- systematic review
- open label
- newly diagnosed
- end stage renal disease
- prognostic factors
- randomized controlled trial
- physical activity
- liver failure
- health insurance
- type diabetes
- mesenchymal stem cells
- intensive care unit
- drug induced
- middle aged
- replacement therapy
- double blind
- weight loss
- patient reported
- aortic dissection
- acute respiratory distress syndrome